Felix Bremmer Selected Research

Urachal cancer

10/2021	Correction to: A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer.
1/2021	A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer.
12/2017	Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Felix Bremmer Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 08/2012
6	Prostatic Neoplasms (Prostate Cancer) 03/2018 - 11/2013
5	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2022 - 09/2015
5	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2013
5	Seminoma 09/2021 - 10/2012
4	Carcinoma (Carcinomatosis) 12/2017 - 10/2012
3	Squamous Cell Carcinoma of Head and Neck 01/2022 - 01/2018
3	Teratoma (Teratoid Tumor) 01/2022 - 10/2012
3	Urachal cancer 10/2021 - 12/2017
2	Diplopia (Double Vision) 01/2020 - 01/2019
2	Headache (Headaches) 01/2020 - 01/2019
2	Embryonal Carcinoma 01/2019 - 10/2012
2	Adenoid Cystic Carcinoma (Cylindroma) 01/2018 - 11/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Proteus Syndrome 01/2022
1	Lipoma (Lipomata) 01/2022
1	Disease Progression 10/2021
1	Lymphatic Metastasis 04/2021
1	Cysts 01/2020
1	Tuberculosis (Tuberculoses) 09/2019
1	Ventilator-Associated Pneumonia 01/2019
1	Adenocarcinoma 10/2018
1	Microsatellite Instability 10/2018
1	Margins of Excision 11/2017
1	Colorectal Neoplasms (Colorectal Cancer) 10/2017
1	Infections 07/2017
1	Thrombosis (Thrombus) 01/2017
1	Nonseminomatous germ cell tumor 09/2015
1	Carcinogenesis 09/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 09/2015
1	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 09/2015
1	Hypoxia (Hypoxemia) 09/2013
1	Tuberous Sclerosis (Bourneville's Disease) 02/2013
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2012

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2015
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
4	AndrogensIBA 03/2018 - 11/2013
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2020
3	Pharmaceutical PreparationsIBA 01/2022 - 05/2013
2	Amino Acids FDA Link 01/2022 - 01/2019
2	IsotopesIBA 01/2022 - 01/2019
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2021 - 01/2020
2	Testosterone (Sustanon)FDA Link 03/2018 - 11/2013
2	Insulin-Like PeptidesIBA 10/2017 - 02/2013
2	Androgen Receptors (Androgen Receptor)IBA 01/2014 - 11/2013
2	Valproic Acid (Depakote)FDA LinkGeneric 05/2013 - 02/2013
2	Cadherins (E-Cadherin)IBA 10/2012 - 08/2012
1	Biological ProductsIBA 01/2022
1	Keratins (Keratin)IBA 01/2022
1	Capsules (Microcapsules)IBA 10/2021
1	stearoyl-coenzyme A (stearoyl-CoA)IBA 04/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	NucleotidesIBA 01/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2020
1	AcidsIBA 09/2019
1	ParaffinIBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	Volatile Organic CompoundsIBA 01/2019
1	Abiraterone AcetateIBA 03/2018
1	enzalutamideIBA 03/2018
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2017
1	Phosphotransferases (Kinase)IBA 10/2017
1	ErbB Receptors (EGF Receptor)IBA 10/2017
1	tyrosine receptor (receptor, tyrosine)IBA 10/2017
1	Estrogen ReceptorsIBA 05/2017
1	FibrinIBA 01/2017
1	Mediator ComplexIBA 09/2015
1	ST 679IBA 09/2015
1	Microfilament Proteins (Actin Binding Proteins)IBA 05/2015
1	Calmodulin-Binding Proteins (Caldesmon)IBA 05/2015
1	Macrophage Colony-Stimulating FactorIBA 02/2014
1	LigandsIBA 11/2013
1	Bromodeoxyuridine (BrdU)IBA 11/2013
1	Carbonic Anhydrase IXIBA 09/2013
1	Indicators and Reagents (Reagents)IBA 09/2013
1	Histones (Histone)IBA 05/2013
1	CyclinsIBA 05/2013
1	Cyclin D2IBA 05/2013
1	Tuberous Sclerosis Complex 1 ProteinIBA 02/2013
1	Tuberous Sclerosis Complex 2 ProteinIBA 02/2013
1	Histone Deacetylase InhibitorsIBA 02/2013
1	Messenger RNA (mRNA)IBA 02/2013
1	temsirolimus FDA Link 02/2013
1	TOR Serine-Threonine KinasesIBA 02/2013
1	Histone Deacetylases (Histone Deacetylase)IBA 02/2013

Therapy/Procedure

11	Therapeutics 01/2022 - 01/2014
4	Castration 03/2018 - 11/2013
1	Operative Surgical Procedures 01/2022
1	Drug Therapy (Chemotherapy) 10/2021
1	Lasers (Laser) 01/2021
1	Decompression 01/2020
1	Spinal Fusion (Spondylosyndesis) 01/2020
1	Artificial Respiration (Mechanical Ventilation) 01/2019
1	Neck Dissection (Radical Neck Dissection) 01/2018
1	Radiotherapy 11/2017
1	Ligation 01/2017